Imperial Valley News Center
San Diego, California - There may be far fewer galaxies further out in the Universe than might be expected, suggests a new study based on simulations conducted using the Blue Waters supercomputer at the National Center for Supercomputing Applications, with resulting data transferred to SDSC Cloud at the San Diego Supercomputer Center at the University of California, San Diego, for future analysis.
San Diego, California - Statins are a hugely popular drug class used to manage blood cholesterol levels and reduce the risk of heart disease. Previous studies had raised questions about adverse behavioral changes with statins, such as irritability or violence, but findings with statins have been inconsistent. In the first randomized trial to look at statin effects on behavior, researchers at the University of California, San Diego School of Medicine report that aggressive behavior typically declined among men placed on statins (compared to placebo), but typically increased among women placed on statins.
San Diego, California - A pair of paleobiologists from Scripps Institution of Oceanography, UC San Diego have determined that the world’s most numerous and diverse vertebrates – ray-finned fishes – began their ecological dominance of the oceans 66 million years ago, aided by the mass extinction event that killed off dinosaurs.
Cambridge, Massachusetts - Instruments that measure the properties of light, known as spectrometers, are widely used in physical, chemical, and biological research. These devices are usually too large to be portable, but MIT scientists have now shown they can create spectrometers small enough to fit inside a smartphone camera, using tiny semiconductor nanoparticles called quantum dots.
Cambridge, Massachusetts - The days of wasting condiments - and other products - that stick stubbornly to the sides of their bottles may be gone, thanks to MIT spinout LiquiGlide, which has licensed its nonstick coating to a major consumer-goods company.
Durham, North Carolina - Researchers at Duke University School of Medicine and Brigham and Women’s Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.
Page 1555 of 2222